Effects of combined Pulsed Dye Laser and Fractional CO


Journal

Burns : journal of the International Society for Burn Injuries
ISSN: 1879-1409
Titre abrégé: Burns
Pays: Netherlands
ID NLM: 8913178

Informations de publication

Date de publication:
09 2021
Historique:
received: 08 06 2020
revised: 13 07 2020
accepted: 07 12 2020
pubmed: 29 12 2020
medline: 22 12 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Hypertrophic burn scars remain a significant burden for patients and a challenge for clinicians. Assessement of the efficacy of combined Pulsed Dye Laser and Ablative Fractional CO Twenty five pediatric subjects were enrolled into the study. Control group consisted of age-matched subjects admitted for surgical repair of inguinal hernia. For the assessment of the results of laser treatment we used the Vancouver scar scale (VSS), and Patient-Observer Scar Assessment Scale (POSAS). We also correlated clinical results with plasma levels of MMP-2, TIMP-1 and alpha-1 type I collagen. All subjects reported the laser treatment resulted in improvement and were somewhat satisfied or very satisfied with their experience. No adverse events were reported. The levels of MMP-2, TIMP-1 and alpha-1 type I collagen in our patients with scars before laser threatment were higher in comparison to controls. We also found statistically significant decrease in the levels of MMP-2, TIMP-1 and alpha-1 type I collagen after laser treatment of burn scars CONCLUSIONS: Our study clearly shows that combined CO2-AFL treatment for burn scars improve texture, colour, function and alleviate pruritus. We believe that decrease in the levels of MMP-2, TIMP-1 and alpha-1 type I collagen after laser treatment of burn scars, reflects reduced dynamic of scar.

Identifiants

pubmed: 33358398
pii: S0305-4179(20)30631-8
doi: 10.1016/j.burns.2020.12.011
pii:
doi:

Substances chimiques

COL1A1 protein, human 0
Collagen Type I 0
Collagen Type I, alpha 1 Chain 0
TIMP1 protein, human 0
Tissue Inhibitor of Metalloproteinase-1 0
Carbon Dioxide 142M471B3J
MMP2 protein, human EC 3.4.24.24
Matrix Metalloproteinase 2 EC 3.4.24.24

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1342-1351

Informations de copyright

Copyright © 2020 Elsevier Ltd and ISBI. All rights reserved.

Auteurs

Ewa Matuszczak (E)

Pediatric Surgery Department, Medical University of Bialystok, Poland; Biophysics Department, Medical University of Bialystok, Poland. Electronic address: ewamat@tlen.pl.

Artur Weremijewicz (A)

Pediatric Surgery Department, Medical University of Bialystok, Poland.

Olga Martyna Koper-Lenkiewicz (OM)

Department of Clinical Laboratory Diagnostics, Medical University of Białystok, Poland.

Joanna Kamińska (J)

Department of Clinical Laboratory Diagnostics, Medical University of Białystok, Poland.

Adam Hermanowicz (A)

Pediatric Surgery Department, Medical University of Bialystok, Poland.

Wojciech Dębek (W)

Pediatric Surgery Department, Medical University of Bialystok, Poland.

Marta Komarowska (M)

Pediatric Surgery Department, Medical University of Bialystok, Poland.

Marzena Tylicka (M)

Biophysics Department, Medical University of Bialystok, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH